Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing ...

Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.

Pfizer's late-stage BRAF V600E-mutant mCRC study of the Braftovi combo regimen meets its other dual primary endpoint of PFS ...

A recent study revealed that bevacizumab (Avastin) provides survival benefits in patients with colorectal cancer (CRC) for ...

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...

The pharmaceutical giant said for 2025 it anticipates sales growth in the mid-single-digit range at constant exchange rates, ...

Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the condition. Sometimes, the better option might be surgery, corrective wear, or ...

The benefits of bevacizumab (Avastin) for the treatment of patients with colorectal cancer (CRC) appear to persist for ...